StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
45
This year
3
Publishing Date
2024 - 03 - 29
1
2024 - 02 - 22
1
2024 - 02 - 12
1
2023 - 12 - 22
1
2023 - 12 - 08
1
2023 - 11 - 17
1
2023 - 10 - 25
1
2023 - 09 - 09
1
2023 - 05 - 31
1
2023 - 03 - 06
1
2023 - 02 - 02
1
2023 - 01 - 19
1
2023 - 01 - 16
1
2022 - 12 - 30
1
2022 - 12 - 28
1
2022 - 11 - 10
1
2022 - 11 - 03
1
2022 - 09 - 06
1
2022 - 08 - 19
1
2022 - 08 - 12
1
2022 - 08 - 11
1
2022 - 07 - 04
1
2022 - 04 - 26
1
2022 - 04 - 21
1
2022 - 04 - 13
1
2022 - 03 - 16
1
2022 - 03 - 08
1
2021 - 08 - 04
1
2021 - 07 - 23
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 17
1
2021 - 06 - 09
1
2021 - 06 - 04
1
2021 - 05 - 24
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 12
1
2021 - 03 - 25
1
2021 - 03 - 19
2
2021 - 03 - 16
1
2021 - 03 - 11
1
Sector
Communications
1
Health technology
45
Manufacturing
4
N/a
3
Process industries
2
Tags
Antiviral
5
Approval
1
Cancer
1
Car-t
1
Covid-19
2
Diagnostics
1
Disease
2
Drug
4
Ema
2
Funding
1
Global
12
Growing
2
Growth
5
Health
1
Hepatitis
1
Hiv
4
Immunotherapy
1
Impact
2
Iot
1
Leukemia
1
Liver
1
Market
22
N/a
44
Patent
1
People
1
Pharma
1
Pharmaceuticals
1
Potential
1
Reach
3
Report
11
Repurposed
1
Research
6
Study
1
T-cell
1
Technology
1
Therapeutics
7
Therapy
5
Treatment
3
Entities
Aadi biosciences inc
3
Abbott laboratories
12
Abbvie inc.
41
Adaptimmune therapeutics plc
3
Allovir, inc.
3
Alnylam pharmaceuticals, inc.
6
Amgen inc.
35
Arcellx, inc.
7
Arcus biosciences, inc.
3
Assembly biosciences, inc.
6
Astellas pharma inc
3
Astrazeneca plc
10
Baxter international inc.
3
Biocryst pharmaceuticals, inc.
13
Biogen inc.
6
Biomarin pharmaceutical inc.
4
Biontech se
3
Bluebird bio, inc.
4
Bristol-myers squibb company
45
Calliditas therapeutics ab
3
Crispr therapeutics ag
3
Cymabay therapeutics inc.
3
Editas medicine, inc.
3
Eli lilly and company
35
Exelixis, inc.
3
Galapagos nv
20
Genmab a/s
4
Gilead sciences, inc.
500
Glaxosmithkline plc
24
Hookipa pharma inc.
16
Humanigen, inc.
3
Immunogen, inc.
4
Intellia therapeutics, inc.
3
Johnson & johnson
43
Jounce therapeutics, inc.
25
Macrogenics, inc.
5
Merck & company, inc.
5
Morphosys ag
4
Novartis ag
28
Novo nordisk a/s
10
Nrx pharmaceuticals inc
3
Nurix therapeutics, inc.
4
Omeros corporation
14
Orange
8
Otonomy, inc.
13
Pfizer, inc.
27
Regeneron pharmaceuticals, inc.
11
Sangamo therapeutics, inc.
4
Sanofi
64
Sarepta therapeutics, inc.
4
Sorrento therapeutics, inc.
4
Takeda pharmaceutical company limited
15
Teva pharmaceutical industries ltd
10
Thermo fisher scientific inc
4
Vertex pharmaceuticals incorporated
6
Veru inc.
4
Viatris inc.
5
Vir biotechnology, inc.
6
Xeris pharmaceuticals, inc.
11
Xilio therapeutics inc
4
Symbols
ABBV
88
ABT
26
ADCT
13
ADXS
8
AGIO
12
ALB
8
ALNY
11
ALPMF
11
ALPMY
11
AMGN
86
AVEO
19
AYLA
12
AZN
61
AZNCF
53
BCRX
13
BGNE
12
BHC
10
BIIB
11
BLUE
8
BMY
662
BOLT
7
BPMC
19
BSX
6
CLVS
20
EPZM
18
EXEL
29
GILD
45
GLAXF
50
GMAB
6
GNMSF
6
GSK
67
ILMN
10
INCY
24
INTS
12
JNJ
91
KPTI
19
LLY
106
MRTX
10
NKTR
7
NVO
7
NVS
103
NVSEF
82
OMER
13
OTIC
13
PFE
61
REGN
30
RIGL
11
SNY
119
SNYNF
70
TAK
43
TEVA
8
TEVJF
37
TPTX
7
TSVT
11
UCBJF
8
UCBJY
8
VSTM
11
VTRS
15
XERS
10
YMAB
18
Exchanges
Nasdaq
45
Nyse
45
Crawled Date
2024 - 03 - 29
1
2024 - 02 - 22
1
2024 - 02 - 12
1
2023 - 12 - 22
1
2023 - 12 - 08
1
2023 - 11 - 17
1
2023 - 10 - 25
1
2023 - 09 - 09
1
2023 - 06 - 01
1
2023 - 03 - 06
1
2023 - 02 - 02
1
2023 - 01 - 19
1
2023 - 01 - 16
1
2022 - 12 - 30
1
2022 - 12 - 28
1
2022 - 11 - 10
1
2022 - 11 - 03
1
2022 - 09 - 06
1
2022 - 08 - 19
1
2022 - 08 - 12
1
2022 - 08 - 11
1
2022 - 07 - 04
1
2022 - 04 - 26
1
2022 - 04 - 21
1
2022 - 04 - 13
1
2022 - 03 - 16
1
2022 - 03 - 08
1
2021 - 08 - 04
1
2021 - 07 - 27
1
2021 - 06 - 24
1
2021 - 06 - 22
1
2021 - 06 - 17
1
2021 - 06 - 09
1
2021 - 06 - 04
1
2021 - 05 - 25
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 13
1
2021 - 03 - 25
1
2021 - 03 - 19
2
2021 - 03 - 16
1
2021 - 03 - 11
1
Crawled Time
00:00
5
04:20
1
08:00
1
10:51
1
11:00
3
12:00
1
12:34
1
13:00
1
13:07
1
13:17
1
13:20
1
13:27
1
14:00
1
14:03
1
14:20
1
14:30
1
15:00
2
15:49
1
16:00
3
17:00
3
17:43
1
18:00
3
18:32
1
19:00
2
19:47
1
20:00
4
21:00
1
22:00
1
Source
www.biospace.com
1
www.fda.gov
14
www.prnewswire.com
30
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Bristol-myers squibb company
symbols :
GILD
save search
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published:
2024-02-22
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.97%
|
O:
0.37%
H:
0.58%
C:
0.58%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.21%
|
O:
0.89%
H:
0.4%
C:
0.17%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-5.63%
|
O:
0.57%
H:
0.47%
C:
-0.58%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-4.68%
|
O:
0.14%
H:
1.01%
C:
0.51%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-5.85%
|
O:
0.29%
H:
0.93%
C:
0.47%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.37%
|
O:
0.97%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-8.27%
|
O:
0.65%
H:
1.35%
C:
0.41%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-5.7%
|
O:
0.47%
H:
2.0%
C:
0.93%
pharmaceuticals
market
Liver Disease Therapeutics Competitive Landscape and Market Forecasts to 2028
Published:
2024-02-12
(Crawled : 20:00)
- prnewswire.com
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-12.2%
|
O:
0.37%
H:
0.74%
C:
0.28%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-1.65%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-3.85%
|
O:
0.8%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.22%
|
O:
-0.06%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-10.33%
|
O:
0.32%
H:
0.11%
C:
-1.55%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-14.72%
|
O:
-2.63%
H:
0.98%
C:
-1.75%
liver
disease
therapeutics
market
Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published:
2023-12-22
(Crawled : 17:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.25%
|
O:
3.66%
H:
0.0%
C:
-0.12%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
4.37%
|
O:
3.33%
H:
0.0%
C:
-2.93%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
18.58%
|
O:
-0.31%
H:
0.39%
C:
-0.44%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-3.65%
|
O:
1.09%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
26.98%
|
O:
0.18%
H:
0.5%
C:
-0.46%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-4.55%
|
O:
-0.78%
H:
5.15%
C:
2.81%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
9.06%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.99%
|
O:
1.03%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
6.53%
|
O:
0.52%
H:
0.58%
C:
0.05%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-15.42%
|
O:
0.34%
H:
1.02%
C:
0.59%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-23.43%
|
O:
0.57%
H:
1.36%
C:
1.04%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.39%
|
O:
1.06%
H:
0.18%
C:
-1.06%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-3.72%
|
O:
0.24%
H:
2.03%
C:
1.49%
patent
report
global
market
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published:
2023-12-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-21.02%
|
O:
-2.79%
H:
0.62%
C:
0.62%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
2.34%
|
O:
2.06%
H:
0.82%
C:
0.82%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-3.34%
|
O:
-1.29%
H:
0.4%
C:
0.4%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-22.51%
|
O:
-2.2%
H:
0.0%
C:
-0.27%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-5.97%
|
O:
-0.64%
H:
0.5%
C:
0.5%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
26.75%
|
O:
-0.42%
H:
0.67%
C:
0.25%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.64%
|
O:
0.19%
H:
0.35%
C:
0.2%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.17%
|
O:
-0.18%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
23.82%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-2.45%
|
O:
0.2%
H:
0.55%
C:
0.1%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
12.6%
|
O:
0.3%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.27%
|
O:
1.07%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-14.47%
|
O:
0.08%
H:
1.45%
C:
1.17%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.88%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
reach
market
HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published:
2023-11-17
(Crawled : 16:00)
- prnewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-1.07%
|
O:
0.78%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-3.76%
|
O:
0.69%
H:
0.06%
C:
-0.68%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
20.34%
|
O:
0.01%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-10.41%
|
O:
0.5%
H:
0.82%
C:
0.75%
reach
research
hiv
market
Global HIV Diagnostics Market Predicted to Reach $1.5 Billion by 2030, with a CAGR of 5.5%
Published:
2023-10-25
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-12.81%
|
O:
-0.18%
H:
1.34%
C:
1.05%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-14.57%
|
O:
-0.31%
H:
0.89%
C:
0.62%
reach
global
hiv
diagnostics
market
Oral Antiviral Market Report 2023: Demand for Novel Therapeutics Boosts Opportunities
Published:
2023-09-09
(Crawled : 04:20)
- prnewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
report
antiviral
therapeutics
market
Global HIV Treatment Market Report 2023: Advances in Gene Therapy Present Significant Opportunities for Sector Growth
Published:
2023-05-31
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
21.03%
|
O:
-0.24%
H:
2.1%
C:
2.1%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
22.95%
|
O:
0.0%
H:
0.66%
C:
0.33%
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
78.61%
|
O:
0.42%
H:
0.83%
C:
-0.41%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.61%
|
O:
-0.34%
H:
0.32%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
18.3%
|
O:
-0.24%
H:
1.43%
C:
0.84%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.07%
|
O:
0.03%
H:
0.41%
C:
0.34%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
20.62%
|
O:
-1.96%
H:
0.0%
C:
-1.35%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
5.18%
|
O:
-0.09%
H:
0.97%
C:
0.89%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-13.23%
|
O:
0.78%
H:
0.0%
C:
-1.72%
report
treatment
global
hiv
therapy
growth
market
Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published:
2023-03-06
(Crawled : 20:00)
- prnewswire.com
CMXHF
|
$172.54
-19.21%
50
|
n/a
|
-10.86%
|
O:
-0.86%
H:
0.33%
C:
0.33%
CSLLY
|
$86.918
3.3%
60K
|
n/a
|
-12.35%
|
O:
-0.02%
H:
0.54%
C:
-1.7%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
4.61%
|
O:
-2.57%
H:
1.62%
C:
1.62%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-2.46%
|
O:
0.41%
H:
0.39%
C:
-2.14%
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
29.77%
|
O:
-1.21%
H:
0.43%
C:
-3.58%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-15.35%
|
O:
0.83%
H:
0.06%
C:
-1.2%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-16.67%
|
O:
0.76%
H:
1.91%
C:
1.26%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
15.38%
|
O:
0.32%
H:
0.17%
C:
-1.53%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
127.71%
|
O:
0.01%
H:
0.42%
C:
-2.62%
CTLT
|
$55.48
-0.57%
-0.4%
1.6M
|
Health Technology
|
-22.23%
|
O:
0.11%
H:
0.53%
C:
-5.05%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-28.98%
|
O:
0.41%
H:
0.04%
C:
-1.71%
ALB
|
$112.15
0.31%
-0.13%
2M
|
Process Industries
|
-56.34%
|
O:
-0.95%
H:
1.02%
C:
-2.19%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
7.17%
|
O:
0.19%
H:
0.06%
C:
-1.7%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.0%
|
O:
0.65%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-17.69%
|
O:
0.23%
H:
0.0%
C:
-1.25%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-28.07%
|
O:
0.28%
H:
0.0%
C:
-2.26%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
6.18%
|
O:
0.9%
H:
0.28%
C:
-1.3%
global
report
market
The Global Antiviral Drugs Market to Exhibit Growth at a Paltry CAGR of ~4% by 2027 | DelveInsight
Published:
2023-02-02
(Crawled : 16:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
28.31%
|
O:
-1.71%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-8.24%
|
O:
-0.16%
H:
0.08%
C:
-0.41%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
6.95%
|
O:
-1.87%
H:
0.01%
C:
-0.55%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-10.31%
|
O:
-1.16%
H:
1.98%
C:
1.56%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-31.31%
|
O:
-1.28%
H:
3.64%
C:
3.48%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
13.51%
|
O:
-0.46%
H:
0.0%
C:
-0.75%
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-72.74%
|
O:
0.62%
H:
2.22%
C:
1.94%
TNXP
|
$0.159
1.27%
1.26%
1.1M
|
Health Technology
|
-97.81%
|
O:
0.85%
H:
5.08%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.63%
|
O:
-1.44%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-20.52%
|
O:
-1.95%
H:
0.16%
C:
-1.18%
global
antiviral
growth
market
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published:
2023-01-19
(Crawled : 17:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
14.14%
|
O:
0.69%
H:
0.0%
C:
-1.52%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-4.71%
|
O:
1.26%
H:
1.19%
C:
1.19%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-17.97%
|
O:
-0.31%
H:
1.15%
C:
0.68%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-12.2%
|
O:
0.13%
H:
0.65%
C:
0.51%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.39%
|
O:
-0.1%
H:
0.31%
C:
0.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-12.87%
|
O:
-0.43%
H:
1.33%
C:
0.3%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
12.96%
|
O:
0.17%
H:
1.36%
C:
1.02%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
106.33%
|
O:
0.1%
H:
0.97%
C:
-0.37%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-32.17%
|
O:
0.29%
H:
2.1%
C:
1.94%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
11.53%
|
O:
-0.17%
H:
1.07%
C:
-0.16%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.95%
|
O:
-0.92%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-20.28%
|
O:
0.51%
H:
0.49%
C:
-0.65%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
1.72%
|
O:
-0.9%
H:
0.58%
C:
0.01%
global
report
growth
market
Global Antiviral Therapeutics Market 2022 to 2027 - Rising Prevalence of Viral Diseases like HIV and Hepatitis Drives Growth
Published:
2023-01-16
(Crawled : 20:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.27%
|
O:
-0.2%
H:
0.0%
C:
0.0%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-45.66%
|
O:
-2.74%
H:
0.43%
C:
-0.99%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-14.71%
|
O:
0.33%
H:
0.33%
C:
-0.94%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-32.52%
|
O:
0.83%
H:
0.52%
C:
-1.09%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.49%
|
O:
-0.01%
H:
0.69%
C:
-0.1%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.05%
|
O:
1.1%
H:
0.22%
C:
0.02%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-22.62%
|
O:
-0.26%
H:
0.37%
C:
-0.74%
COCP
|
$1.495
-1.39%
7.6K
|
Health Technology
|
-28.5%
|
O:
0.47%
H:
11.16%
C:
7.91%
hepatitis
global
antiviral
hiv
therapeutics
growth
market
Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published:
2022-12-30
(Crawled : 15:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.69%
|
O:
0.77%
H:
0.0%
C:
-0.74%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
0.81%
|
O:
1.08%
H:
0.0%
C:
-0.25%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-49.35%
|
O:
-0.08%
H:
0.21%
C:
-0.1%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
3.01%
|
O:
-0.01%
H:
0.08%
C:
-0.95%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-16.7%
|
O:
-0.04%
H:
0.16%
C:
-0.47%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-32.14%
|
O:
0.04%
H:
0.21%
C:
-0.25%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.63%
|
O:
-0.39%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-21.7%
|
O:
0.08%
H:
0.66%
C:
0.61%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
43.81%
|
O:
-0.32%
H:
2.91%
C:
2.75%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.66%
|
O:
-0.46%
H:
0.38%
C:
0.01%
global
disease
report
therapeutics
cancer
market
Hagens Berman Sobol Shapiro LLP, Hilliard & Shadowen LLP, and Durie Tangri LLP Announce a Class Action Involving Antiretroviral Drugs
Published:
2022-12-28
(Crawled : 21:00)
- prnewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-16.27%
|
O:
0.5%
H:
0.42%
C:
0.01%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-32.03%
|
O:
0.43%
H:
0.47%
C:
-0.28%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-21.06%
|
O:
0.4%
H:
0.78%
C:
0.41%
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published:
2022-11-10
(Crawled : 17:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
29.9%
|
O:
-0.06%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
13.03%
|
O:
6.22%
H:
3.13%
C:
-0.56%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
13.73%
|
O:
2.81%
H:
0.43%
C:
-0.2%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-15.07%
|
O:
0.18%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
22.61%
|
O:
2.59%
H:
0.72%
C:
0.63%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-38.67%
|
O:
1.22%
H:
0.01%
C:
-1.7%
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
44.26%
|
O:
6.12%
H:
4.99%
C:
4.21%
INO
4 d
|
$9.68
-5.1%
-5.37%
350K
|
Health Technology
|
344.04%
|
O:
5.5%
H:
4.35%
C:
3.48%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-18.9%
|
O:
1.43%
H:
0.36%
C:
-1.08%
ATRA
|
$0.6755
-2.34%
-2.4%
1.6M
|
Health Technology
|
-82.99%
|
O:
2.58%
H:
23.12%
C:
20.85%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
12.29%
|
O:
7.08%
H:
0.84%
C:
-0.43%
ADAP
|
$0.97
7.97%
7.38%
1.5M
|
Health Technology
|
-53.33%
|
O:
0.0%
H:
7.14%
C:
5.71%
covid-19
research
global
immunotherapy
report
impact
technology
market
Pediatric Health Market Research Report by Type, Therapeutics, Treatment, Treatment Type, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published:
2022-11-03
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
6.86%
|
O:
-0.02%
H:
0.43%
C:
0.43%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
12.61%
|
O:
-1.02%
H:
2.67%
C:
0.18%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
41.88%
|
O:
2.28%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
16.34%
|
O:
0.83%
H:
1.33%
C:
-0.51%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
17.39%
|
O:
1.13%
H:
0.63%
C:
0.53%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
100.82%
|
O:
0.97%
H:
0.18%
C:
-2.13%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-37.65%
|
O:
0.42%
H:
0.59%
C:
-0.04%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
11.23%
|
O:
1.43%
H:
0.41%
C:
0.25%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
9.12%
|
O:
2.05%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-15.98%
|
O:
-0.4%
H:
2.75%
C:
1.52%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
14.38%
|
O:
0.72%
H:
1.29%
C:
1.04%
covid-19
treatment
research
global
report
impact
health
market
Disease-Modifying Antirheumatic Drug (DMARD) Market to Surpass US$ 27,167.8 Million by 2030 - Coherent Market Insights
Published:
2022-09-06
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
17.12%
|
O:
-3.02%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
87.86%
|
O:
0.73%
H:
2.28%
C:
1.72%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.8%
|
O:
-0.65%
H:
0.93%
C:
0.71%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-28.73%
|
O:
0.03%
H:
1.18%
C:
0.13%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
20.95%
|
O:
-0.03%
H:
1.08%
C:
0.84%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
16.23%
|
O:
0.49%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
5.32%
|
O:
0.44%
H:
2.03%
C:
1.76%
CPIX
|
$1.65
6.02%
790
|
Health Technology
|
-27.6%
|
O:
-4.52%
H:
7.12%
C:
5.69%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
11.03%
|
O:
0.24%
H:
1.04%
C:
0.82%
drug
market
Red Biotechnology Market to Exceed US$ 609.6 Bn by 2031: TMR Study
Published:
2022-08-19
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
4.63%
|
O:
3.04%
H:
0.12%
C:
-2.22%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-6.63%
|
O:
-2.05%
H:
0.29%
C:
0.07%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-46.48%
|
O:
0.54%
H:
1.24%
C:
0.63%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-34.01%
|
O:
0.01%
H:
2.09%
C:
1.58%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
43.53%
|
O:
-0.62%
H:
0.57%
C:
-0.42%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
2.42%
|
O:
-0.25%
H:
1.19%
C:
0.49%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.08%
|
O:
0.78%
H:
0.49%
C:
0.22%
study
market
Global Engineered T Cells Market Report 2022-2027: Immuno-Oncology Sector Increasing R&D Funding & Expanding Gene Therapy Marketspace Generating High-Potential Opportunities
Published:
2022-08-12
(Crawled : 14:20)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
34.17%
|
O:
1.51%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
10.26%
|
O:
-0.61%
H:
0.9%
C:
0.73%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-34.29%
|
O:
0.16%
H:
1.53%
C:
1.33%
DTIL
|
$9.75
-9.05%
-9.95%
170K
|
Health Technology
|
497.55%
|
O:
0.61%
H:
23.78%
C:
22.56%
PSTX
|
$2.02
1.0%
0.99%
640K
|
Health Technology
|
-50.85%
|
O:
-1.7%
H:
12.62%
C:
8.91%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
6.9%
|
O:
0.42%
H:
0.45%
C:
0.4%
CABA
|
$13.31
-4.72%
-4.96%
1.2M
|
Health Technology
|
820.0%
|
O:
2.76%
H:
4.7%
C:
2.68%
BLCM
|
$0.0748
381.28%
6.1K
|
Health Technology
|
-94.73%
|
O:
3.58%
H:
1.99%
C:
-1.41%
ATNX
|
$0.2031
-7.78%
1.9M
|
Health Technology
|
-62.24%
|
O:
2.25%
H:
0.0%
C:
0.0%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
8.29%
|
O:
0.07%
H:
0.54%
C:
-0.05%
global
report
funding
therapy
market
← Previous
1
2
3
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.